IMAGE DESCRIPTION: Photo of a woman undergoing a CPET. Photo of Dr Charles Shepherd. Heading - Research Square: Preprint: ME/CFS and LC Demonstrate Bioenergetic Impairment and Recovery Failure on Two-Day CPET. ME Association logo.

Research Square: Preprint: ME/CFS and LC Demonstrate Bioenergetic Impairment and Recovery Failure on Two-Day CPET

AI Summary

  • Participants completed two cardiopulmonary exercise tests (CPETs) 24 hours apart, which measure oxygen use and work capacity during exertion and can reveal impaired recovery after activity.
  • Both ME/CFS and Long Covid groups showed reduced oxygen consumption and workload compared with healthy controls at the ventilatory anaerobic threshold.
  • Performance worsened on the second test despite normal heart and lung function. Findings support the use of two-day CPET as an objective measure of PEM and functional impairment.

The preprint for a new paper titled, ‘ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing,‘ has been published on Research Square, and is currently undergoing peer review at Clinical & Translational Metabolism.

Abstract:

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long Covid are characterized by post-exertional malaise (PEM). Similarities in disease presentation suggest important commonalities in bioenergetic impairment, but this hypothesis has not been demonstrated. The metabolic underpinnings of each disease can be elucidated by two cardiopulmonary exercise tests (CPET) administered 24 hours apart.

This retrospective study examined physiological responses on two-day CPET in people with ME/CFS (63 females and 21 males), Long Covid (52 females and 27 males), and matched non-disabled control participants (51 females and 20 males). Data were analyzed within sexes using repeated measures analysis of variance. All participants met maximal effort criteria.

There were significant reductions in oxygen consumption (O₂) and workload at the ventilatory anaerobic threshold (VAT) in both patient groups compared to non-disabled controls, with larger effect sizes at VAT than at peak exertion. Performance decrements were observed in both sexes. Females exhibited more pronounced abnormalities and significant group by test effects. No significant differences were observed between patient groups. Severe disability based on impaired O₂ was prevalent in both patient groups. Hemodynamic and ventilatory measures were within normal ranges.

ME/CFS and Long Covid both involve a functionally significant bioenergetic failure complicated by inadequate post-exertional recovery, which is similar between the conditions and unexplained by hemodynamic and ventilatory changes. Findings support the utility of two-day CPET as an objective measure of PEM and functional impairment. Future studies may integrate mechanistic biomarkers with two-day CPET as trial endpoints and to establish likely responses to treatments for PEM.

MEA Comment:

This is a report on findings from new research into the use of cardiopulmonary exercise testing in people with ME/CFS and Long Covid.

It comes from Professor Todd Davenport and colleagues at the Workwell Foundation in America.

Main conclusion: No significant differences were observed between patient groups. Severe disability based on impaired O₂ was prevalent in both patient groups. Hemodynamic and ventilatory measures were within normal ranges. ME/CFS and Long Covid both involve a functionally significant bioenergetic failure complicated by inadequate post-exertional recovery, which is similar between the conditions and unexplained by hemodynamic and ventilatory changes.

Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association,
Member of the 2018-2021 NICE guideline on ME/CFS committee,
Member of the 2002 Chief Medical Officer's Working Group on ME/CFS

Charles Shepherd
Shopping Basket
Scroll to Top